AMETEK (AME) director Karleen Oberton receives 950-share restricted stock grant

Rhea-AI Filing Summary

Oberton Karleen Marie reported acquisition or exercise transactions in this Form 4 filing.

AMETEK Inc. director Karleen Marie Oberton received a grant of 950 shares of Common Stock, constituting restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. The award was valued at $212.77 per share on the grant date. Following this grant, she directly holds 5,640 shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Oberton Karleen Marie

(Last) (First) (Middle)

250 CAMPUS DRIVE

(Street)

MARLBOROUGH MASSACHUSETTS 01752

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AMETEK INC/ [ AME ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/18/2026		A(1)		950	A	$212.77	5,640	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Constitutes restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan.

Remarks:

	/s/ Lynn Carino, attorney-in-fact for Ms. Oberton	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did AMETEK (AME) report for Karleen Marie Oberton?

AMETEK reported that director Karleen Marie Oberton received a grant of 950 shares of Common Stock as restricted stock under the 2020 Omnibus Incentive Compensation Plan, reflecting equity-based compensation rather than an open-market share purchase.

Was the AMETEK (AME) Form 4 transaction a stock purchase or an award?

The Form 4 shows an award, not an open-market purchase. Oberton received 950 restricted shares coded as a grant or award (transaction code A), issued under AMETEK’s 2020 Omnibus Incentive Compensation Plan as part of her director compensation.

At what price was Karleen Oberton’s AMETEK (AME) stock award valued?

The 950-share restricted stock grant to Karleen Oberton was valued at $212.77 per share on the transaction date. This value reflects the grant price disclosed for the award, not cash paid by the director in a market transaction.

How many AMETEK (AME) shares does Karleen Oberton hold after the reported transaction?

After receiving the 950-share restricted stock grant, Karleen Oberton directly holds a total of 5,640 AMETEK Common Stock shares. This total represents her direct ownership position immediately following the equity compensation award disclosed in the Form 4.

What plan governed the restricted stock granted to AMETEK (AME) director Karleen Oberton?

The restricted stock grant to Karleen Oberton was issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. This plan authorizes equity-based awards, such as restricted stock, used to compensate directors and align their interests with shareholders.

Does the AMETEK (AME) Form 4 indicate any stock sales by Karleen Oberton?

The Form 4 does not report any stock sales by Karleen Oberton. It shows only a single acquisition coded as a grant or award of 950 restricted shares, increasing her direct holdings to 5,640 shares after the transaction.